Gene:
ABCG8
ATP-binding cassette, sub-family G (WHITE), member 8

Overview

Alternate Names: ATP-binding cassette sub-family G member 8; ATP-binding cassette, sub-family G (WHITE), member 8 (sterolin 2); ATP-binding cassette, subfamily G, member 8; sterolin 2
Alternate Symbols: ABCG8; GBD4; MGC142217; STSL
PharmGKB Accession Id: PA24412

Details

Cytogenetic Location: chr2 : p21
GP mRNA Boundary: chr2 : 43919607 - 43959109
GP Gene Boundary: chr2 : 43909607 - 43962109
Strand: plus
Product Name: ATP-binding cassette, subfamily G, member 8, sterolin 2
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

Curated Annotations (Curated Annotation)

  1. rs11887534 at chr2:43919751 in ABCG5, ABCG8
    In a GWAS of cases and controls from an unspecificied population, rs11887534 was found to be associated with gallstones. This finding was replicated in German and Chilean populations.
    Variant Name:
    ABCG8:D19H
    Related Diseases:
    Cholelithiasis
    Evidence:
    PMID:17632509
  2. rs4299376 at chr2:43926080 in ABCG5, ABCG8
    In a case-control study of European populations, rs4299376 was found to be associated with risk of gallstones.
    Related Diseases:
    Cholelithiasis
    Evidence:
    PMID:17632509

Non-Curated Annotations (Non-Curated Annotation)

  1. rs6756629 at chr2:43918594 in ABCG5, ABCG8
    GWAS results: Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. (Initial Sample Size: 22,562 individuals; Replication Sample Size: NR); (Region: 2p21; Reported Gene(s): ABCG5; Risk Allele: rs6756629-G); (p-value= 0.00000000002).This variant is associated with Cholesterol, total.
    Evidence:
    PMID:19060911
    http://www.genome.gov/gwastudies/
  2. rs6756629 at chr2:43918594 in ABCG5, ABCG8
    GWAS results: Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. (Initial Sample Size: 17,797 individuals; Replication Sample Size: NR); (Region: 2p21; Reported Gene(s): ABCG5; Risk Allele: rs6756629-G); (p-value= 0.0000000003).This variant is associated with LDL cholesterol.
    Evidence:
    PMID:19060911
    http://www.genome.gov/gwastudies/
  3. rs11887534 at chr2:43919751 in ABCG5, ABCG8
    GWAS Results: A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease (Initial Sample Size: 280 cases, 360 controls; Replication Sample Size: 2,000 cases, 1,202 controls; Risk Allele: rs11887534-C).
    Related Diseases:
    Cholelithiasis
    Evidence:
    PMID:17632509
    http://www.genome.gov/gwastudies/
  4. rs6544713 at chr2:43927385 in ABCG5, ABCG8
    GWAS results: Common variants at 30 loci contribute to polygenic dyslipidemia. (Initial Sample Size: 19,840 individuals; Replication Sample Size: Up to 20,623 individuals); (Region: 2p21; Reported Gene(s): ABCG8; Risk Allele: rs6544713-T); (p-value= 2E-20).This variant is associated with LDL cholesterol.
    Evidence:
    PMID:19060906
    http://www.genome.gov/gwastudies/
Variant names are different names that have been used in the literature and other resources to refer to the same variant. Non-curated variant information is accumulated solely by computational methods and has not been verified by the scientific staff at PharmGKB.

Non-Curated Information

A list of non-curated publications that mention this gene along with other genes is available.

PharmGKB Curated Pathways

Reactome Pathways

External pathways not curated by PharmGKB.

Curated Information

The following drugs are in curated knowledge about this gene.

  Drug Class Relationship Evidence
Phenotype data available Genotype Data Available Literature annotations available Not annotated
hmg coa reductase inhibitors
  •   
  • PD
  •   
  •   
  •   
Pathways
  Drug Relationship Evidence
No phenotype data No genotype data Literature annotations available Not annotated
atorvastatin
  •   
  • PD
  •   
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
ezetimibe
  •   
  • PD
  •   
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
fluvastatin
  •   
  • PD
  •   
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
lovastatin
  •   
  • PD
  •   
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
pravastatin
  •   
  • PD
  •   
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
rosuvastatin
  •   
  • PD
  •   
  •   
  •   
Pathways
Phenotype data available No genotype data Literature annotations available Not annotated
simvastatin
  •   
  • PD
  •   
  •   
  •   
Pathways

Non-Curated Information

A list of non-curated publications that mention this gene along with other drugs is available.

Curated Information

The following diseases are in curated knowledge about this gene.

  Disease Relationship Evidence
Phenotype data available Genotype Data Available Literature annotations available Not annotated
Cardiovascular Diseases
  •   
  • PD
  •   
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Cholelithiasis
  • CO
  •   
  •   
  •   
  • GN
Publications, Variants
No phenotype data No genotype data Literature annotations available Not annotated
Hypercholesterolemia
  •   
  • PD
  •   
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Hyperlipidemias
  •   
  • PD
  •   
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Hyperlipoproteinemia Type II
  •   
  • PD
  •   
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Muscular Diseases
  •   
  • PD
  •   
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Myalgia unspecified
  •   
  • PD
  •   
  •   
  •   
Pathways
Phenotype data available Genotype Data Available Literature annotations available Not annotated
Myocardial Infarction
  •   
  • PD
  •   
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Myositis
  •   
  • PD
  •   
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Rhabdomyolysis
  •   
  • PD
  •   
  •   
  •   
Pathways
No phenotype data No genotype data Literature annotations available Not annotated
Sitosterolemia
  • CO
  •   
  •   
  •   
  • GN
Publications

Non-Curated Information

A list of non-curated publications that mention this gene along with other diseases is available.

LinkOuts

Entrez Gene ID:
64241
OMIM Accession:
210250
605460
611465
UCSC Genome Browser ID:
NM_022437
Ref Seq NM Accession:
NM_022437
Ref Seq NP Accession:
AAG40004
AAI13658
AAI43565
AAK84078
AAK84663
AAK85386
AAK85389
AAY24011
EAX00285
NP_071882
Q14CR0
Q96A01
Q9H221
SOURCE ID:
ABCG8
MutDB ID:
ABCG8
PromoLign ID:
ortho_860
HuGE ID:
ABCG8
Comparative Toxicogenomics Acc ID:
64241
ModBase:
Q9H221

Common Searches

Non-Curated Publications

A list of non-curated publications that mention this gene is available.

The PharmGKB is financially supported by the NIH/ NIGMS and is managed at Stanford University (U01GM61374).
©2001-2010 PharmGKB.